Castillo C - Search Results

1

Medical assessment in drug addicts: reliability and validity of the Cumulative Illness Rating Scale (Substance Abuse version).

Castillo C, Bulbena A, Serras E, Torrens M, López-Colomés JL, Martínez MA, Politinska B. Castillo C, et al. Eur Addict Res. 2004;10(3):112-7. doi: 10.1159/000077699. Eur Addict Res. 2004. PMID: 15258441

2

Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.

San L, Torrens M, Castillo C, Porta M, de la Torre R. San L, et al. Among authors: castillo c. Addiction. 1993 Oct;88(10):1341-9. doi: 10.1111/j.1360-0443.1993.tb02020.x. Addiction. 1993. PMID: 8251871

3

Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment.

Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J. Torrens M, et al. Among authors: castillo c. Addiction. 1997 Jun;92(6):707-16. Addiction. 1997. PMID: 9246798 Clinical Trial.

4

Monitoring patterns of substance use in drug-dependent patients.

San L, Torrens M, Tato J, Castillo C, de la Torre R, Arranz B. San L, et al. Among authors: castillo c. J Subst Abuse Treat. 1998 Sep-Oct;15(5):425-30. doi: 10.1016/s0740-5472(97)00289-4. J Subst Abuse Treat. 1998. PMID: 9750999 Clinical Trial.

5

Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender.

Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvarós J, Castillo C, Magrí N, Martín S, Vázquez JM. Puigdollers E, et al. Among authors: castillo c. Subst Use Misuse. 2004 Jul;39(9):1353-68. doi: 10.1081/ja-120039392. Subst Use Misuse. 2004. PMID: 15462234

6

Methadone maintenance treatment in Spain: the success of a harm reduction approach.

Torrens M, Fonseca F, Castillo C, Domingo-Salvany A. Torrens M, et al. Among authors: castillo c. Bull World Health Organ. 2013 Feb 1;91(2):136-41. doi: 10.2471/BLT.12.111054. Bull World Health Organ. 2013. PMID: 23554526 Free PMC article.

7

Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification.

San L, Tato J, Torrens M, Castillo C, Farré M, Camí J. San L, et al. Among authors: castillo c. Drug Alcohol Depend. 1993 May;32(3):281-6. doi: 10.1016/0376-8716(93)90093-6. Drug Alcohol Depend. 1993. PMID: 8102333

8

Retention in a low-threshold methadone maintenance program.

Torrens M, Castillo C, Pérez-Solá V. Torrens M, et al. Among authors: castillo c. Drug Alcohol Depend. 1996 May;41(1):55-9. doi: 10.1016/0376-8716(96)01230-6. Drug Alcohol Depend. 1996. PMID: 8793310

9

Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.

Torrens M, Castillo C, San L, del Moral E, González ML, de la Torre R. Torrens M, et al. Among authors: castillo c. Drug Alcohol Depend. 1998 Nov 1;52(3):193-200. doi: 10.1016/s0376-8716(98)00096-9. Drug Alcohol Depend. 1998. PMID: 9839145

10

Analytical methodology for the detection of benzodiazepine consumption in opioid-dependent subjects.

Segura M, Barbosa J, Torrens M, Farré M, Castillo C, Segura J, de la Torre R. Segura M, et al. Among authors: castillo c. J Anal Toxicol. 2001 Mar;25(2):130-6. doi: 10.1093/jat/25.2.130. J Anal Toxicol. 2001. PMID: 11300505

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,245 results

Search Page

Filters